Skip to main content
. Author manuscript; available in PMC: 2018 Apr 9.
Published in final edited form as: Psychiatry Res. 2017 Aug 1;257:372–374. doi: 10.1016/j.psychres.2017.07.070

Fig. 1.

Fig. 1

Selected subjective ratings before and after marijuana administration as a function of group (Clinical High-Risk [CHR], left side; Controls, right side). On x-axis: B = baseline; MJ = marijuana administration. Error bars reflect SEM. †main effect of drug condition; $drug condition × time interaction; *active (5.5% THC) differs from placebo (0.0% THC); p < 0.05. Full ANOVA results in Table S2.